Connor, Clark & Lunn Investment Management (CC&L)’s Viemed Healthcare VMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-95,242
Closed -$751K 1723
2023
Q4
$751K Sell
95,242
-318,058
-77% -$2.31M ﹤0.01% 942
2023
Q3
$2.77M Sell
413,300
-52,400
-11% -$429K 0.01% 529
2023
Q2
$4.56M Buy
465,700
+241,800
+108% +$2.46M 0.02% 415
2023
Q1
$2.17M Buy
223,900
+86,300
+63% +$752K 0.01% 535
2022
Q4
$1.04M Sell
137,600
-4,000
-3% -$27.1K 0.01% 691
2022
Q3
$851K Buy
141,600
+30,900
+28% +$198K 0.01% 692
2022
Q2
$599K Buy
110,700
+75,000
+210% +$404K ﹤0.01% 737
2022
Q1
$180K Sell
35,700
-3,600
-9% -$16.7K ﹤0.01% 953
2021
Q4
$205K Sell
39,300
-66,300
-63% -$370K ﹤0.01% 976
2021
Q3
$586K Sell
105,600
-92,900
-47% -$605K ﹤0.01% 741
2021
Q2
$1.42M Sell
198,500
-111,900
-36% -$969K 0.01% 616
2021
Q1
$3.16M Sell
310,400
-103,840
-25% -$977K 0.02% 453
2020
Q4
$3.24M Sell
414,240
-155,500
-27% -$1.37M 0.02% 416
2020
Q3
$4.94M Buy
569,740
+78,840
+16% +$795K 0.03% 309
2020
Q2
$4.71M Buy
490,900
+473,750
+2,762% +$3.68M 0.03% 307
2020
Q1
$81K Sell
17,150
-169,850
-91% -$842K ﹤0.01% 952
2019
Q4
$1.17M Buy
187,000
+30,000
+19% +$208K 0.01% 517
2019
Q3
$1.08M Buy
+157,000
New +$1.05M 0.01% 528

Other funds holding VMD

Connor, Clark & Lunn Investment Management (CC&L)'s VMD Position: Q1 2024 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Viemed Healthcare (VMD) in Q1 2024, closing a stake of 95,242 shares — an estimated $751K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in VMD in Q3 2019 and held it in 18 quarters. The position peaked at $4.94M in Q3 2020. 112 funds tracked by Wall St. Rank hold VMD as of Q1 2024.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Viemed Healthcare position as of Q1 2024 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 95,242 Viemed Healthcare shares in Q1 2024, an estimated $751K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Viemed Healthcare in Q3 2019 and held it in 18 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Viemed Healthcare position peaked at $4.94M in Q3 2020.
  • 112 funds tracked by Wall St. Rank held Viemed Healthcare as of Q1 2024.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2024, filed 9 May 2024.